Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Jiangsu Hengrui Medicine patents PTPN11 inhibitors

July 20, 2022

Novel CDK9 inhibitor with good antiproliferative activity in hematologic cancer models

July 20, 2022

Novel HDAC3 inhibitor shows antitumor activity in 4T1-Luc xenograft mouse model

July 19, 2022

Abbisko Therapeutics describes new GTPase KRAS inhibitors

July 19, 2022

Medshine Discovery patents IRAK4 and BTK inhibitors

July 19, 2022

PDE5A targeting enhances chemotherapy efficacy in esophageal adenocarcinoma

July 19, 2022

Janssen Pharmaceutica presents new Mcl-1 inhibitors

July 18, 2022

Amgen describes new PRMT5 inhibitors

July 15, 2022

KDM4B enzyme inhibitor tested for aggressive rhabdomyosarcoma

July 14, 2022

GLS1 inhibitor with antitumor activity in HCT116 xenograft model

July 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...